Chonnam Med J.  2011 Aug;47(2):111-115. 10.4068/cmj.2011.47.2.111.

Clinical Features and Rate of Infective Endocarditis in Non-Faecalis and Non-faecium Enterococcal Bacteremia

• Jang HC
• Park WB
• Kim HB
• Kim EC
• Oh MD

• KMID: 2048794
• DOI: http://doi.org/10.4068/cmj.2011.47.2.111

Abstract

Non-faecalis and non-faecium enterococci are an occasional cause of bacteremia, and some cases of infective endocarditis caused by these pathogens have been reported. However, the rate of infective endocarditis in non-faecalis and non-faecium enterococcal bacteremia is still undetermined. We compared the clinical features and the rate of infective endocarditis of 70 cases of non-faecalis and non-faecium enterococcal bacteremia with those of 65 cases of Enterococcus faecalis bacteremia. Non-faecalis and non-faecium enterococcal bacteremia was more frequently associated with biliary tract infection and polymicrobial bacteremia, and was less frequently associated with infective endocarditis, than was E. faecalis bacteremia (57% vs. 28%, p<0.01; 47% vs. 31%, p=0.05; 1% vs. 14%, p<0.01, respectively).

Keyword

Enterococci; Bacteremia; vanC; Endocarditis

MeSH Terms

Bacteremia
Biliary Tract
Endocarditis
Enterococcus faecalis

Reference

1. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev. 1990. 3:46–65.

2. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis. 1995. 20:296–301.

3. Choi SH, Lee SO, Kim TH, Chung JW, Choo EJ, Kwak YG, et al. Clinical features and outcomes of bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum: analysis of 56 cases. Clin Infect Dis. 2004. 38:53–61.

4. de Perio MA, Yarnold PR, Warren J, Noskin GA. Risk factors and outcomes associated with non-Enterococcus faecalis, non-Enterococcus faecium enterococcal bacteremia. Infect Control Hosp Epidemiol. 2006. 27:28–33.

5. Ratanasuwan W, Iwen PC, Hinrichs SH, Rupp ME. Bacteremia due to motile Enterococcus species: clinical features and outcomes. Clin Infect Dis. 1999. 28:1175–1177.

6. Reid KC, Cockerill FR III, Patel R. Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clin Infect Dis. 2001. 32:1540–1546.

7. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009. 169:463–473.

8. Talarmin JP, Pineau S, Guillouzouic A, Boutoille D, Giraudeau C, Reynaud A, et al. Relapse of Enterococcus hirae prosthetic valve endocarditis. J Clin Microbiol. 2011. 49:1182–1184.

9. Poyart C, Lambert T, Morand P, Abassade P, Quesne G, Baudouy Y, et al. Native valve endocarditis due to Enterococcus hirae. J Clin Microbiol. 2002. 40:2689–2690.

10. Ortu M, Gabrielli E, Caramma I, Rossotti R, Gambirasio M, Gervasoni C. Enterococcus gallinarum endocarditis in a diabetic patient. Diabetes Res Clin Pract. 2008. 81:e18–e20.

11. Dargere S, Vergnaud M, Verdon R, Saloux E, Le Page O, Leclercq R, et al. Enterococcus gallinarum endocarditis occurring on native heart valves. J Clin Microbiol. 2002. 40:2308–2310.

12. Stepanović S, Jovanović M, Lavadinović L, Stosović B, Pelemis M. Enterococcus durans endocarditis in a patient with transposition of the great vessels. J Med Microbiol. 2004. 53:259–261.

13. Mirzoyev Z, Anavekar N, Wilson F, Uslan D, Baddour L, Mookadam F. Enterococcus avium endocarditis. Scand J Infect Dis. 2004. 36:876–878.

14. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991. 115:585–590.

15. Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Ann Intern Med. 2001. 135:484–492.

16. Devriese LA, Pot B, Kersters K, Lauwers S, Haesebrouck F. Acidification of methyl-alpha-D-glucopyranoside: a useful test to differentiate Enterococcus casseliflavus and Enterococcus gallinarum from Enterococcus faecium species group and from Enterococcus faecalis. J Clin Microbiol. 1996. 34:2607–2608.

17. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 1989. 27:731–734.

18. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. 2008. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI);M100-S18.

19. Courvalin P. Vancomycin resistance in gram-positive cocci. Clin Infect Dis. 2006. 42:Suppl 1. S25–S34.

20. Elliott TS, Foweraker J, Gould FK, Perry JD, Sandoe JA. Working Party of the British Society for Antimicrobial Chemotherapy. Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2004. 54:971–981.

21. Watanakunakorn C, Patel R. Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin. Clin Infect Dis. 1993. 17:74–78.

22. Graninger W, Ragette R. Nosocomial bacteremia due to Enterococcus faecalis without endocarditis. Clin Infect Dis. 1992. 15:49–57.

23. Gullberg RM, Homann SR, Phair JP. Enterococcal bacteremia: analysis of 75 episodes. Rev Infect Dis. 1989. 11:74–85.

24. Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore). 1988. 67:248–269.

25. Jang HC, Lee S, Song KH, Jeon JH, Park WB, Park SW, et al. Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance. J Korean Med Sci. 2010. 25:3–8.

26. Anderson DJ, Murdoch DR, Sexton DJ, Reller LB, Stout JE, Cabell CH, et al. Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study. Infection. 2004. 32:72–77.

27. Billot-Klein D, Gutmann L, Sablé S, Guittet E, van Heijenoort J. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum. J Bacteriol. 1994. 176:2398–2405.

28. Sahm DF, Free L, Handwerger S. Inducible and constitutive expression of vanC-1-encoded resistance to vancomycin in Enterococcus gallinarum. Antimicrob Agents Chemother. 1995. 39:1480–1484.